New imaging test for bowel inflammation in IBD
Part of Digestive system clinical trials.
This study tests a new imaging technique that uses a special dye and a camera during a routine colonoscopy to see how leaky the bowel lining is. It may help doctors understand inflammation better and could lead to better treatments for IBD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have ulcerative colitis or Crohn's disease that affects the colon, or be having a colonoscopy for other reasons.
- You must be scheduled for a colonoscopy as part of your care.
- You must not be allergic to fluorescein (a yellow dye used in the test).
- You must not have certain health conditions like kidney failure, severe heart or lung disease, or an active infection.
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging technique that may help doctors see inflammation more clearly during colonoscopy in people with Crohn's disease or ulcerative colitis. The technique is called Texture and Color Enhancement Imaging (TXI).
This study tests a new camera system that adds texture and color enhancement to the usual white light during a colonoscopy. It aims to see if this new view helps doctors spot signs of inflammation or early cancer more clearly in people with inflammatory bowel disease.
This study compares two ways of looking at the colon during a routine check-up to find early signs of cancer in people with inflammatory bowel disease (IBD). One method uses a special light, and the other uses a dye. The goal is to see which is better at finding these signs.
This study uses a special camera capsule to map the gut's natural bacteria in people with ulcerative colitis or Crohn's disease, compared to healthy volunteers. The goal is to better understand how these bacteria affect the disease, which could lead to better treatments.
This study tests a new magnetic flexible endoscope for examining the colon in people with stable inflammatory bowel disease, such as ulcerative colitis or Crohn's disease. The aim is to see if this gentler approach can help visualize the colon more comfortably.
This study checks whether adding an extra, cross-body “transmural” evaluation (looking at inflammation throughout the bowel) improves care for adults with Crohn’s who are starting or receiving biologic (biotherapy) treatment. It uses close follow-up with stool calprotectin (a marker of gut inflammation) to see if this approach helps control inflammation.
Hear when a new Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.